
Biogen has announced that its investigational gene therapy study for the potential treatment of choroideremia did not meet its primary …

A UK Phase I trial of a gene therapy designed to restore sight in patients suffering from an inherited form …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

